INTRODUCTION {#S1}
============

BCL-2 family proteins participate in cell death ^[@R1][@R2]-[@R4][@R5][@R6],\ [@R7]^ but one member of the family, Bcl-x~L~, is the predominant anti-apoptotic protein expressed in healthy adult brain ^[@R8]^ suggesting that it performs other physiological functions. In hippocampal neurons, over-expression of Bcl-x~L~ markedly changes synaptic morphology ^[@R9]^. In the squid giant presynaptic terminal, recombinant BcL-x~L~ protein enhances the rate of recovery of neurotransmission following intense synaptic activity ^[@R10]^ while the Bcl-2/BcL-x~L~ inhibitor ABT-737 slows recovery ^[@R11]^.

Bcl-x~L~ also regulates neuronal metabolism by enhancing the efficiency of mitochondrial ATP production^[@R12]^. Mobilization of synaptic vesicles from the reserve pool depends on mitochondria^[@R13]^. Following physiological exoctyosis, however, recovery of neurotransmitter pools is also determined by endocytotic retrieval of vesicles directly from the plasma membrane. The molecular machinery regulating retrieval includes the clathrin coat, which interacts with molecules that catalyze fission of synaptic vesicles from the plasma membrane^[@R14],\ [@R15]^ and calcium dependent proteins and phosphatases which catalyze endocytosis^[@R16],\ [@R17]^. Both reserve pool mobilization and direct plasma membrane retrieval contribute to recovery in hippocampus^[@R18]^.

We have now found using imaging techniques in hippocampal neurons that Bcl-x~L~ regulates recovery to a fast-releasing vesicle pool. Surprisingly, enhanced vesicle recovery produced by Bcl-x~L~ occurs even when effects of mitochondrial ATP are eliminated. Bcl-x~L-~regulated recovery depends on stimulation, calmodulin and Bcl-x~L~ translocation to clathrin-coated pits. At synaptic vesicles, Bcl-x~L~ forms protein/protein interactions with the dynamin-like GTPase Drp1. Depletion of Drp1 or disruption of its interaction with Bcl-x~L~ slows endocytosis and produces aberrantly shaped vesicle membranes. We suggest that a Bcl-x~L~-Drp1-clathrin complex directly enhances vesicle retrieval from the plasma membrane and contributes to enlargement of a fast-releasing pool during presynaptic plasticity.

RESULTS {#S2}
=======

Bcl-x~L~ over expression enhances the rate of release of styryl dyes in hippocampal neurons {#S3}
-------------------------------------------------------------------------------------------

To study the role of Bcl-x~L~ in vesicle exo- and endocytosis, we over-expressed GFP-Bcl-x~L~ or GFP control lentivirus constructs in cultured hippocampal neurons (DIV 14)^[@R9]^ and measured the kinetics of release of the styryl dye FM-5-95 at individual synapses after loading with 47 mM KCl, 2 mM CaCl~2~ for 90 s, a protocol reported to label recycling vesicles ([Fig. 1a](#F1){ref-type="fig"}, Exp 1)^[@R19]-[@R21]^. Peak fluorescence of labeled presynaptic clusters and total change in fluorescence (ΔF) were significantly higher in Bcl-x~L~ over-expressing cells compared to controls ([Fig. 1d](#F1){ref-type="fig"} and [Supple. Fig. 1a](#SD2){ref-type="supplementary-material"}) consistent with previous findings that Bcl-x~L~ increases presynaptic vesicle cluster size by light and electron microscopy ^[@R9]^. Greater than 90% of dye was released within the first 90 s of stimulation in 90 mM KCl ([Supple Fig. 1b](#SD2){ref-type="supplementary-material"}), therefore only the first 90 s are shown in subsequent studies. In controls, release kinetics at room temperature were well fit with a single exponential ([Fig. 1b, e, f](#F1){ref-type="fig"}); in all control experiments, fewer than 20% of puncta displayed bi-exponential kinetics of fluorescence decline. Relative weights of fits to rapid and slow components of release demonstrated that release in control cells had little or no rapid component ([Fig. 1g](#F1){ref-type="fig"}). In contrast to controls, the kinetics of dye release in more than 90% of Bcl-x~L~ over-expressing neurons required a fit with two exponentials ([Fig. 1b, e, f](#F1){ref-type="fig"}); the rapid component of release represented as much as one third or more of the total release ([Fig. 1g](#F1){ref-type="fig"}). These data show that both controls and Bcl-x~L~ expressing cells have a slowly releasing pool, but that Bcl-x~L~ over-expressing cells have an additional pool that releases more rapidly.

Vesicle pool loading is regulated by calcium influx ^[@R20]^. To determine if increased pool loading was related to calcium influx, calcium responses in GFP-Bcl-x~L~ and control GFP expressing cells were monitored with the calcium indicator fluo-4 during stimulation with 100 APs at 10 Hz. No difference in calcium levels at boutons between Bcl-x~L~ overexpressing cells and controls was detected ([Fig. 1c](#F1){ref-type="fig"}), suggesting that differences in calcium influx at release sites do not contribute to differences in vesicle release.

In hippocampal neurons, filling of the fast-releasing pool takes longer than it does, for example, in the Calyx of Held^[@R17],\ [@R22]^; therefore refilling of the fast-releasing pool might take longer in controls compared to Bcl-x~L~ expressing cells. To test this, we allowed for continued dye loading after stimulation during a 5 minute re-filling period ([Fig. 1a](#F1){ref-type="fig"}, Exp 2)^[@R20]^. Using this protocol Bcl-x~L~ over-expressing cells again demonstrated larger peak fluorescence than control neurons ([Fig. 1h](#F1){ref-type="fig"} and [Supple Fig. 1a](#SD2){ref-type="supplementary-material"}), but kinetics of dye release from both Bcl-x~L~ and control neurons now required a fit with two exponentials ([Fig. 1i-k](#F1){ref-type="fig"}). Therefore, like Bcl-x~L~ cells, control cells have a rapidly releasing pool, but this pool takes longer to fill than in Bcl-x~L~ cells.

The late-filling fast-releasing pool may continue to fill long after stimulation has ceased. If the fast-releasing pool fills faster in Bcl-x~L~ overexpressing cells, then there should exist a time after stimulation that the fast-releasing pool would be filled in the Bcl-x~L~ expressing cells but not in controls. To test if controls fill the fast-releasing pool long after stimulation, dye was presented for 90 s only at 3 minutes after the end of stimulation ([Fig. 1a](#F1){ref-type="fig"}, Exp 3). In both controls and Bcl-x~L~ over-expressing cells, there was a lower level of peak fluorescence than in Exp 1 and 2 ([Fig. 1l](#F1){ref-type="fig"} and [Supple Fig. 1a](#SD2){ref-type="supplementary-material"}), suggesting only partial filling of recovering pools; the filled pool sizes, however, of the two cell types were now not different from each other, therefore a large portion in Bcl-x~L~ over-expressing cells filled early. In addition, in Bcl-x~L~ cells, there was complete elimination of bi-exponential kinetics, suggesting Exp 3 eliminated filling of the fast-releasing pool ([Fig. 1m-o](#F1){ref-type="fig"}). In controls however, release kinetics of some cells now required bi-exponential fits ([Fig. 1n-o](#F1){ref-type="fig"}), suggesting very late re-filling of the fast-releasing pool.

Endogenous Bcl-x~L~ participates in normal vesicle pool dynamics {#S4}
----------------------------------------------------------------

To determine if endogenous Bcl-x~L~ regulates normal exo-endocytosis we reduced levels of Bcl-x~L~ with Bcl-x~L~ shRNA or scrambled shRNA lentivirus and studied release properties of the recycling pool (Exp 1; [Fig. 2a](#F2){ref-type="fig"} and [Supple Fig. 1a](#SD2){ref-type="supplementary-material"}). Cells expressing Bcl-x~L~ shRNA had decreased peak fluorescence compared to controls ([Fig. 2b](#F2){ref-type="fig"} and [Supple. Fig. 1a](#SD2){ref-type="supplementary-material"}), confirming an effect on overall pool size^[@R9]^. Kinetics of the slowly releasing pool were decreased in Bcl-x~L~ depleted cells ([Fig. 2c-e](#F2){ref-type="fig"}) suggesting that Bcl-x~L~ regulates the rate of exo-endocytosis of both the rapidly and slowly releasing pools.

Bcl-x~L~ acts downstream of calmodulin to enhance endocytosis {#S5}
-------------------------------------------------------------

Re-filling of at least two vesicle pools in the Calyx of Held is dependent on calcium/calmodulin^[@R23],\ [@R24]^, therefore inhibition of calmodulin could affect pool dynamics in hippocampal cells. Control neurons treated with the calmodulin inhibitor calmidazolium (CaMi, 20 μM for 30 min) during exo-endocytosis to the recycling pool manifested decreased peak fluorescence ([Fig. 2f](#F2){ref-type="fig"} and [Supple Fig. 1a](#SD2){ref-type="supplementary-material"}) and a decreased time constant of release ([Fig. 2g-i](#F2){ref-type="fig"}), suggesting that CaMi prevented re-filling of a slowly-releasing pool. If CaMi-sensitive pools were sensitive to Bcl-x~L~, then Bcl-x~L~ over-expression might rescue release kinetics in CaMi-exposed neurons. Consistent with this, CaMi treatment failed to decrease peak fluorescence in Bcl-x~L~-over-expressing cells ([Fig. 2j](#F2){ref-type="fig"}) and, although CaMi slowed bi-exponential kinetics ([Fig. 2k, l](#F2){ref-type="fig"}), Bcl-x~L~ rescued the fast releasing pool in CaMi-treated cells ([Fig. 2m](#F2){ref-type="fig"}). Therefore Bcl-x~L~ could act downstream of calmodulin in re-filling of vesicle pools.

Bcl-x~L~ increases rate of endocytosis in synaptopHluorin expressing neurons {#S6}
----------------------------------------------------------------------------

Experiments on exo- and endocytosis using styryl dyes provide an indirect measure of the kinetics of endocytosis^[@R25]^. A direct measure is obtained using synaptopHluorin, a green fluorescent synaptic vesicle protein that increases its fluorescence upon exocytosis, when the lumen of synaptic vesicles is exposed to the relatively high pH of the external medium^[@R26]-[@R29]^. Upon endocytosis, fluorescence intensity declines, and the kinetics of decline reflect the rate of vesicle retrieval plus the rate of re-acidification of the vesicle lumen^[@R29]^. Using synaptopHluorin, Bcl-x~L~ overexpressing cells had higher peak fluorescence compared to controls during stimulation, as expected by the increased pool size ([Fig. 3a](#F3){ref-type="fig"}). In addition, the time constant of the decrease in fluorescence following the end of stimulation was faster than in controls ([Fig. 3a](#F3){ref-type="fig"} inset). Bcl-x~L~ over-expressing cells had an increase in peak fluorescence compared to control cells after addition of the vesicle re-acidification inhibitor bafilomycin (control data shown in [Fig. 3b, d](#F3){ref-type="fig"}; Bcl-x~L~ over-expressing cell data shown in [Fig. 3c, d](#F3){ref-type="fig"}) suggesting that Bcl-x~L~ over-expressing neurons perform more endocytosis during exocytosis compared to controls. In contrast, neurons expressing DsRed Bcl-x~L~ shRNA had slower fluorescence decline ([Fig. 3e](#F3){ref-type="fig"} and inset) and a decrease in peak fluorescence in bafilomycin (controls shown in [Fig. 3f, h](#F3){ref-type="fig"}; DsRed Bcl-x~L~ shRNA shown in 3g, h), indicating that Bcl-x~L~ is necessary for early pool loading during exocytosis. To control for off-target effects of shRNA, DsRed Bcl-x~L~ shRNA-expressing cells were transfected with an shRNA-resistant Bcl-x~L~ construct. This construct rescued the effects of Bcl-x~L~ depletion on protein level ([Suppl. Fig. 2a, b](#SD3){ref-type="supplementary-material"}) and synaptopHluorin fluorescence changes ([Fig. 3i](#F3){ref-type="fig"}), confirming that the effect of Bcl-x~L~ shRNA was specific. The small molecule Bcl-x~L~ inhibitor ABT-737^[@R11],\ [@R30]^ ([Fig. 3j](#F3){ref-type="fig"}) also decreased the rate of decline in synaptopHluorin fluorescence after stimulation compared to that measured before ABT-737 exposure ([Fig. 3j](#F3){ref-type="fig"} inset).

Reports have emphasized a role for Bcl-x~L~ in enhancing ATP availability for cell survival^[@R31],\ [@R32]^. If the sole effect of Bcl-x~L~ were to enhance ATP production by mitochondria the effects of Bcl-x~L~ on vesicle dynamics would be eliminated under conditions of fixed ATP such as in autaptically synapsing cells patch-clamped with ATP (1 mM) in the recording pipette ([Fig. 3k](#F3){ref-type="fig"}; see methods). Under these conditions, synaptic depression was less in Bcl-x~L~ over-expressing cells than controls ([Fig. 3l, m](#F3){ref-type="fig"}), suggesting that Bcl-x~L~ relieved synaptic depression, in part in an ATP-independent manner. To eliminate mitochondrial ATP production altogether, we exposed cells to the F~1~F~O~ ATP synthase enzymatic inhibitor oligomycin. In the absence of oligomycin, as previously reported^[@R12]^, overexpression of Bcl-x~L~ increased ATP levels over control neurons ([Fig. 3n](#F3){ref-type="fig"}); 5 min. of exposure to oligomycin completely eliminated this difference ([Fig 3n](#F3){ref-type="fig"}). Oligomycin also prolonged the time course of endocytosis more in controls than cells overexpressing Bcl-x~L~ ([Fig. 3o, p](#F3){ref-type="fig"}). Nevertheless, the difference in ratio of peak fluorescence before and after bafilomycin exposure comparing Bcl-x~L~ expressing cells to controls ([Fig. 3q-s](#F3){ref-type="fig"}) was preserved in the presence of oligomycin (compare [Fig. 3s to Fig. 3d](#F3){ref-type="fig"}). These data suggest that a portion of early endocytosis in Bcl-x~L~-expressing neurons is unaffected by loss of mitochondrial ATP.

Neuronal stimulation promotes calmodulin-dependent Bcl-x~L~ translocation to synaptic vesicle membranes {#S7}
-------------------------------------------------------------------------------------------------------

During strong synaptic stimulation or injurious stimuli such as ischemia in neurons, large amounts of calcium enter the cell and are buffered by calcium buffering proteins, mitochondria and the endoplasmic reticulum. In cells that have received such stimuli, Bcl-x~L~ translocates to intracellular membranes perhaps to enhance synaptic responses and protect against cell injury^[@R33]-[@R36]^. To measure acute translocation of Bcl-x~L~ to intracellular membranes after stimulation, cells were immediately lysed and subjected to sub-cellular fractionation for Bcl-x~L~ immunoanalysis. The level of contamination of subcellular fractions with proteins specific to other fractions was low either before or after stimulation ([Suppl. Fig. 2d](#SD3){ref-type="supplementary-material"}) and the fraction containing synaptic vesicle protein (synaptotagmin-1) was relatively devoid of post-synaptic protein (PSD-95), presynaptic compartment or presynaptic membrane proteins ([Suppl. Fig. 2e](#SD3){ref-type="supplementary-material"}). Levels of endogenous Bcl-x~L~ after stimulation decreased in the cytosol and increased in mitochondria and in the synaptic vesicle membrane compartment ([Fig. 4a, b](#F4){ref-type="fig"}). Bcl-x~L~ translocation was largely prevented by pre-teatment with CaMi ([Fig. 4a, b](#F4){ref-type="fig"}), suggesting calmodulin is upstream of translocation. To rule out non-specific effects of calmodulin inhibition, neurons were depleted of endogenous calmodulin by shRNA (calmodulin protein blot [Supple. Fig.2c](#SD3){ref-type="supplementary-material"}). Translocation of Bcl-x~L~ was largely prevented in calmodulin depleted cultures ([Fig. 4c, d](#F4){ref-type="fig"}), suggesting that calmodulin is necessary for Bcl-x~L~ translocation to both mitochondria and synaptic vesicle membranes during neuronal activity. Endogenous calmodulin also regulated early endocytosis, since neurons expressing calmodulin shRNA had a lower ratio of endocytosis to exocytosis measured with and without bafilomycin ([Fig. 4e-g](#F4){ref-type="fig"}) and a slower rate of synaptopHluorin fluorescence decline ([Fig. 4h](#F4){ref-type="fig"} and inset).

Bcl-x~L~ and Drp1 are co-localized with clathrin on synaptic vesicles and Drp1 regulates endocytotic vesicle morphology {#S8}
-----------------------------------------------------------------------------------------------------------------------

Previous work suggested that Bcl-x~L~ co-localizes with and activates, via protein-protein interaction, the GTPase activity of Drp1 ^[@R9],\ [@R37]^. Drp1 is a large dynamin-like GTPase usually associated with mitochondrial fission events in both physiological and pathological settings^[@R9],\ [@R37]-[@R41]^. We therefore determined if Drp1, in its role as a dynamin-like GTPase, might regulate endocytosis. Indeed, immuno-electron micrographs demonstrated that Drp1, although clearly localized in part to mitochondria ([Suppl. Fig. 3a](#SD4){ref-type="supplementary-material"}) was also co-localized with clathrin at clathrin-coated pits in neurons fixed just after stimulation ([Fig. 5a](#F5){ref-type="fig"}) and translocated to synaptic vesicles in a stimulation-calmodulin dependent manner ([Suppl. Fig. 3b](#SD4){ref-type="supplementary-material"}). Furthermore, clathrin, Bcl-x~L~ and the Drp1 mitochondrial targeting protien Mff, but not dynamin or non-vesicular proteins (PSD-95 or Cacna1a) were present in immunoblots of brain tissue immunoprecipitated with anti-Drp1 antibody ([Fig. 5b](#F5){ref-type="fig"}). The Bcl-x~L~/Drp1/Mff/clathrin complex was also present in the purified synaptic vesicle fraction ([Fig. 5c, d](#F5){ref-type="fig"}). The anti-Drp1 antibody was specific to Drp1 in that it did not recognize dynamin in brain lysates; the anti-Dynamin I and II antibody was also specific in brain lysates ([Suppl. Fig. 3c](#SD4){ref-type="supplementary-material"}).

Bcl-x~L~ co-localizes with and activates the GTPase activity of Drp1 to alter membrane properties^[@R9],\ [@R42]^. To test if Drp1 influences normal exo-endocytosis, synaptopHluorin-expressing neurons were depleted of Drp1 by lentivirus encoding shRNA ([Supple Fig. 2f](#SD3){ref-type="supplementary-material"}); depletion of Drp1 was confirmed by immunoblots ([Suppl. Fig. 2g, h](#SD3){ref-type="supplementary-material"}) and in randomly generated immuno-electron micrographs of equal numbers of synaptic profiles ([Suppl. Fig. 2i](#SD3){ref-type="supplementary-material"}). We found previously that depletion of Drp1 or expression of a dominant negative defective Drp1 does not prevent mitochondrial entry into axons and dendrites, but increases the length of mitochondria in neuronal processes^[@R9],\ [@R37],\ [@R43]^. In the current study, Drp1 depletion increased individual mitochondrial area measured in electron micrographs (0.14 +/- 0.02 μ^2^, N=18 mitochondria in controls compared to 0.30 +/- 0.03 μ^2^, N=20 mitochondria in Drp1 shRNA, p = 0.0011), consistent with hyperfused mitochondria. Both peak fluorescence and rate of synaptopHluorin re-uptake in Drp1 depleted cells were decreased compared to scrambled shRNA controls ([Fig. 5e](#F5){ref-type="fig"}) but Drp1 depletion was rescued by over-expression of an shRNA-resistant Drp1 construct, suggesting that Drp1 is specifically required for normal exo-endocytosis ([Fig. 5f](#F5){ref-type="fig"}). Peak fluorescence ratio of bafilomycin-treated cells expressing Drp1 shRNA was decreased compared to controls (control data shown in [Fig. 5g, i](#F5){ref-type="fig"}; Drp1 shRNA data shown in [Fig. 5h, i](#F5){ref-type="fig"}), indicating that Drp1, like Bcl-x~L~, is necessary for early vesicle re-uptake during exocytosis.

Drp1 is recruited to mitochondria via the mitochondrial fission factor Mff ^[@R44]^. Mff coimmunoprecipitated with Drp1 in brain lysates, but also in purified synaptic vesicle lysates ([Fig. 5b-d](#F5){ref-type="fig"}) and also co-immunoprecipitated with the specific vesicle membrane protein synaptotagmin ([Fig. 5j](#F5){ref-type="fig"}). Depletion of Mff by shRNA produced a decline in the rate of endocytosis and a decrease in early endocytosis ([Fig. 5k-m](#F5){ref-type="fig"}). Taken together, the findings suggest that Mff may serve as the targeting protein for Drp1 to synaptic vesicle membranes and that Mff contributes to vesicle retrieval from the plasma membrane after stimulation.

Bcl-x~L~ and Drp1-Mff previously were known to function at mitochondrial membranes, not synaptic vesicle membranes. Therefore, to confirm localization at synaptic vesicle membranes, immunogold electron microscopy was performed. Clathrin was co-localized with Bcl-x~L~ at clathrin-coated pits in control synapses ([Fig. 6a](#F6){ref-type="fig"}). Bcl-x~L~ was present in brain tissue immunoprecipitated with anti-clathrin antibody ([Fig. 6b](#F6){ref-type="fig"}), although synaptic proteins that are known not to bind clathrin (dynamin, Cacna1a and PSD-95) were absent, suggesting specific association of Bcl-x~L~ with clathrin. Formation of the Bcl-x~L~-clathrin complex depended on neuronal stimulation: gold particles labeled with antibodies to clathrin and Bcl-x~L~ were increasingly co-localized after stimulation (N=27) compared to non-stimulated synapses (N=25; [Fig. 6c](#F6){ref-type="fig"}).

Bcl-x~L~ and Drp1 were found to be localized to mitochondria, but also at synaptic vesicle membranes with the presynaptic vesicle marker synaptophysin ([Fig. 6d, f](#F6){ref-type="fig"}). Labeling with synaptophysin was specific because it was restricted to synaptic vesicle membranes. Labeling of Bcl-x~L~ and Drp1 was specific, because it was restricted to synaptic vesicle membranes and to mitochondria but little labeling was seen at other subcellular locations including post synaptic sites ([Fig. 6d, f](#F6){ref-type="fig"}). Bcl-x~L~ and Drp1 co-localized with synaptic vesicle components in a stimulation dependent manner; both Bcl-x~L~ and Drp1 were increased in synaptic profiles after stimulation and co-localization with synaptophysin was increased ([Fig.6 e](#F6){ref-type="fig"}).

A morphologically apparent defect in endocytosis occurred in Drp1 depleted resting cultured neurons ([Fig. 7a-c](#F7){ref-type="fig"}). Images of scrambled shRNA-expressing synapses only occasionally displayed enlarged endosomal or vesicular structures ([Fig. 7a](#F7){ref-type="fig"}) whereas images of Drp1 shRNA-expressing synapses showed multiple large vesicular structures ([Fig. 7b](#F7){ref-type="fig"}). In addition, measurable synaptic vesicle area in electron micrographs of Drp1-depleted synapses was more variable and contained larger vesicles than controls ([Fig. 7c](#F7){ref-type="fig"}). It is likely that enlarged structures represent either vesicles delayed in the process of endocytosis, enlarged as a result of abnormally flat membrane curvature or abnormally fused with partner vesicles.

Electron micrographs of stimulated HRP-labeled synapses demonstrated a similar bizarre endosomal phenotype as seen in non-stimulated neurons, and this phenotype was rarely present in controls ([Fig. 7d](#F7){ref-type="fig"}). As was the case for non-stimulated synapses, the average area of HRP-labeled vesicles was significantly larger in Drp1-depleted cells compared to controls ([Fig. 7e](#F7){ref-type="fig"}). The large endosomal structures in stimulated Drp1 depleted neurons co-localized with the specific synaptic vesicle protein VAMP on immuno-electron micrographs ([Fig. 7f and i](#F7){ref-type="fig"}), suggesting they had the phenotype of synaptic vesicles. In addition, unlike in controls, where large endosomal structures were observed rarely before stimulation ([Fig. 7g](#F7){ref-type="fig"} top and quantification in [7h](#F7){ref-type="fig"}), after Drp1 depletion, abnormal vesicular profiles including long tubular and enlarged endosomal/vesicular structures were present almost equally in stimulated and resting cells ([Fig. 7g](#F7){ref-type="fig"} bottom and quantification in [7i](#F7){ref-type="fig"}), suggesting that abnormal structures may be delayed in devolving into normal vesicles.

In normal neurons undergoing stimulation, the plasma membrane perimeter (synapse profile area) may increase as exocytotic membrane is added to it; concomitantly the number of intra-synaptic vesicles is decreased after fusion^[@R45]^. We found in control neurons that the area of synaptic profiles was not changed after stimulation, but that the number of synaptic vesicles was decreased ([Fig. 7j, k](#F7){ref-type="fig"}). In contrast, in Drp1-depleted cells, the number of synaptic vesicles was unchanged after stimulation but synaptic profile area was decreased, perhaps consistent with re-uptake of enlarged membranes and lack of re-formation of vesicles ([Fig. 7j, k](#F7){ref-type="fig"}). Interestingly, synaptic profile area and number of vesicles in unstimulated Drp1-depleted synapses were significantly decreased compared to unstimulated controls, consistent with the notion that Drp1-depleted synapses are unable to maintain normal vesicle pool sizes.

Bcl-x~L~/Drp1 interaction is required for regulation of endocytosis {#S9}
-------------------------------------------------------------------

To confirm the role in endocytosis of the Bcl-x~L~/Drp1 complex, mutations in Bcl-x~L~ were designed *de novo.* We mutated conserved amino acids between human Bcl-x~L~ and Bcl-2-like protein CED-9 of *Caenorhabditis elegans*, since both proteins interact with Drp1 ^[@R9],\ [@R46]^. Mutation of three consecutive conserved amino acid residues in the BH1 domain and three conserved residues in the BH2 domain generated constructs M1 and M2 ([Fig. 8a](#F8){ref-type="fig"}). Immunoprecipitation by anti-FLAG antibody of wild type and M1 FLAG-tagged Bcl-x~L~ proteins pulled down over-expressed Drp1 in HEK293T cells, while FLAG-tagged M2 Bcl-x~L~ protein failed to interact with over-expressed Drp1 ([Fig. 8b](#F8){ref-type="fig"}). Over-expression of wild type Bcl-x~L~ and M1 equally enhanced synaptopHluorin responses in hippocampal neurons, but over-expression of M2 failed to enhance responses over the control level ([Fig. 8c, d](#F8){ref-type="fig"}). The synaptopHluorin experiments and analyses were performed by an operator blinded to the results of the co-immunoprecipitation studies. The Bcl-x~L~/Drp1 complex therefore enhances endocytosis through a mechanism involving direct interaction between the two proteins ([Fig. 8e](#F8){ref-type="fig"}).

DISCUSSION {#S10}
==========

We suggest that Bcl-x~L~, previously known to protect against cell death, also regulates vesicle endocytosis in hippocampal neurons. We show that Bcl-x~L~ interacts in a complex with clathrin and Drp1 to alter the kinetics of vesicle pool recovery.

We have previously shown in squid that Bcl-x~L~ protein enhances recovery to a rapidly releasing neurotransmitter pool following synaptic depression^[@R10]^ and that endogenous Bcl-x~L~ regulates this recovery^[@R11]^. Although at least two pools regulate vesicle recovery at the Calyx of Held and squid, hippocampal presynaptic terminals do not display the same fast time kinetics as these synapses^[@R10],\ [@R47]^. Although previous work in other synapses suggested that transmitter recovery was regulated by mitochondria^[@R10]^, we find a pool in hippocampus that is resistant to mitochondrial metabolism. Nevertheless, it is likely that other synaptic processes in hippocampus are dependent on mitochondrial function^[@R9],\ [@R48]^.

Release kinetics in the hippocampus are determined by calcium-dependent synaptic vesicle priming, fusion, and recycling. In support of a role for calcium-dependent processes, we find that inhibition of calmodulin by pharmacological or genetic means prevents Bcl-x~L~ and Drp1 translocation to synaptic vesicles during stimulation and prevents normal vesicle pool recovery. In this form of clathrin-dependent endocytosis, we find that Bcl-x~L~ and Drp1 act downstream of calcium influx/calmodulin. Our studies are also consistent with recent results defining a role for calmodulin in vesicle release probability^[@R49]^. Indeed, our electron micrographs of Drp1-depleted cells demonstrate a lack of change in vesicle number after stimulation, suggesting defective exocytosis.

Previous studies support a role for BCL-2 family proteins including Bcl-x~L~ in altering lipid membrane morphology in cell-free systems^[@R50]-[@R53]^. Bcl-x~L~ may change membrane morphology through its actions on Drp1. GTPases participate in membrane fission events of several subcellular organelles. Drp1 acts downstream of Bcl-x~L~^[@R9],\ [@R37]^ and upstream of endophilin B1 in regulating mitochondrial membrane remodeling^[@R54]^. Endophilin family members also play a role in synaptic endocytosis^[@R55]-[@R58]^. The GTPases at vesicles interact with AP2, epsin, amphiphysin and AP180 ^[@R15],\ [@R59]^ to alter membrane curvature and achieve scission of the vesicle from the plasma membrane. We find that interaction of Bcl-x~L~ with Drp1 is necessary for normal vesicle retrieval; a mutation in the Bcl-x~L~ BH2 domain decreases interaction with Drp1 and inhibits Bcl-x~L~-induced increase in endocytosis rate. We find that the mitochondrial docking protein Mff^[@R44]^ also recruits Drp1 to synaptic vesicles. However, the mechanism by which Mff recruits Drp1 to synaptic vesicles vs. mitochondria is not known.

Drp1 has been implicated previously, albeit indirectly, in the regulation of synaptic vesicle endocytosis. In *Drosophila* synapses, Drp1 knockout produces loss of mitochondrial targeting to synapses and a metabolically dependent decline in sustained synaptic responses^[@R13],\ [@R60]^. Previous work also supports a role for Drp1 in hippocampal synapse formation and enlargement. Expression of a dominant negative form of Drp1 decreases mitochondrial targeting to synapses and decreases synapse formation even though it lengthens mitochondria in neuronal processes^[@R9]^. Nevertheless, a direct role for Drp1 at synaptic vesicle membranes has not been anticipated previously. Our current study shows that Drp1 depletion enlarges endocytotic figures creating abnormally flat membrane curvature, associated with delayed vesicle recovery to release ready pools. Based on our findings the order of events in healthy synapses undergoing exo/endocytosis would be 1) calcium entry into the terminal, 2) activation of calmodulin, 3) translocation of Bcl-x~L~/Drp1 to the synaptic vesicle membrane, 4) binding of Bcl-x~L~/Drp1 to a complex including Mff and clathrin, 5) enhancement of the rate of retrieved membrane to re-form into exocytosis-ready vesicles ([Fig. 8e](#F8){ref-type="fig"}). It is tempting to speculate based on these data that a complex of proteins involving Bcl-x~L~, Drp1 and clathrin, in cooperation with other known vesicle membrane-regulating proteins, is necessary for efficient endocytosis and presynaptic plasticity.

EXPERIMENTAL PROCEDURES {#S11}
=======================

Primary cultures of rat hippocampal neurons and transfections {#S12}
-------------------------------------------------------------

Primary rat hippocampal neurons were prepared as described previously ^[@R61],\ [@R62]^. Briefly, hippocampi were isolated from Sprague-Dawley rat embryos (E18--E19), and then incubated for 12 min with 0.03% trypsin. The hippocampal cells were dissociated by trituration through a polished Pasteur pipette. Neurons were plated on 0.1% (w/v) poly-L-lysine (Peptides International, Louisville, KY) coated coverslips (Warner Instruments, Hamden, CT) at a density of 3--6 ×10^3^ cm^-1^. Cells were cultured in Neurobasal medium, supplemented with B-27 (Invitrogen, Carlsbad, CA), 0.5mM glutamine, 25 μM glutamate, and 5% fetal calf serum. 3-4 hr after plating, the medium was replaced with serum-free Neurobasal supplemented with B-27 and 0.5mM glutamine. Cultures typically contained few glial cells, started to form synapses after 6 days *in vitro*, and were used 9 to 20 days after plating. Neurons were transfected with 2.5 M calcium phosphate at day 5 after plating with an efficiency of \~1 - 5%. Neurons were transduced with the lentiviral construct for Bcl-x~L~ at DIV 4-7 days and studied at DIV 12-18 with an efficiency of near 100%.

Viral constructs {#S13}
----------------

Lentiviruses expressing Bcl-x~L~ with an N-terminal GFP tag were used to transduce cultured hippocampal neurons. Full length GFP- Bcl-x~L~ was subcloned into a lentivirus vector c-FUW ^[@R63]^. Viral constructs were packaged in 293T cells by co-transfection with packaging plasmid delta 8.9 and envelope plasmid VSVG.48. 60h after transfection, virus-containing supernatant was collected, stored at −80°C, and used for transduction of cultured hippocampal neurons on DIV-5.

Autaptic primary hippocampal neuron culture {#S14}
-------------------------------------------

Briefly, the center of each coverslip was treated with a 0.15% type IIA agarose solution and coverslips were dried for 1 h ^[@R64]^. Micro-islands were prepared 2 days before plating hippocampal neurons. by spraying coverslips with 1:4 vol./vol. mixture of collagen and poly-D-lysine using a Glass micro-atomizer (Thomas Scientific, Swedesboro, NJ, USA). After drying, the coverslips were UV sterilized for 5 min. then pre-incubated for 1 h with neurobasal (+B27) medium + 10%FBS before plating with dissociated hippocampal cells at a density of 0.2--0.6×10^4^ cells/ml. Island cultures were maintained for upwards of 6 weeks, typically cells were recorded at DIV 30.

Lentiviral shRNA knockdown of Bcl-x~L~, Mff, Calmodulin and Drp-1 and the shRNA-resistant constructs {#S15}
----------------------------------------------------------------------------------------------------

The lentiviral plasmids, expressing short hairpin RNAs (shRNA) were from Open Biosystems, USA. Lentiviral plasmids for Drp1 shRNA were designed as in ^[@R45]^. The hairpin sequence against rat Bcl-x~L~ was: CGGGCTCACTCTTCAGTCGGAATAGTGAAGCCACAGATGTATTCCGACTGAAGAGTGAGCCCA For control, the scrambled, nonsilencing shRNA sequence (Open Biosystems catalog no. RHS4346) was used. The lentivirus was produced according to published methods ^[@R61]^. The pGIPZ vectors, containing either shRNA sequence against Bcl-x~L~ or the scrambled sequence were co-transfected with the packaging Δ8.9 and the vesicular stomatitis virus G protein vectors into HEK 293T cells. 48 hours after transfection, the supernatant was centrifuged at 50,000×g. The viral pellet was resuspended in PBS and added to the hippocampal neuronal cultures DIV 5-7 and studied DIV 12-14. For the ds-RED constructs, the shRNA sequences targeting rat Bcl-x~L~, Calmodulin1+2 and Drp1 were cloned through a shuttle vector pCMV-U6 into a modified version of the lentiviral expression vector FlkURW (1) creating FU6siGURW (includes the U6 promoter in front of the Ubiquitin promoter/dsRED2 expression cassette). The structure of the shRNA hairpins was sense-loop-antisense. The shRNA sequences were: Bcl-x~L~ up: TTTggagtcagtttagcgatgtcgGTGAAGCCACAGATGcgacatcgctaaactgactccTTTTTBcl-x~L~ down: CGAAAAAggagtcagtttagcgatgtcgCATCTGTGGCTTCACcgacatcgctaaactgactcCalm 1+2 up: TTTgaagctttctccctatttgaGTGAAGCCACAGATGtcaaatagggagaaagcttcTTTTTCalm 1+2 down: CGAAAAAgaagctttctccctatttgaCATCTGTGGCTTCACtcaaatagggagaaagcttDrp1 up: TTTgacatcatccagctgcctcagGTGAAGCCACAGATGctgaggcagctggatgatgtcTTTTTDrp1 down: CGAAAAAgacatcatccagctgcctcagCATCTGTGGCTTCACctgaggcagctggatgatgtThe shRNA sequence against Mff was: 5'-**GATCGTGGTTACAGGAAATAA-3'.** The Bcl-x~L~ and Drp1 shRNA-resistant constructs were made using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies, USA) according to the manufacturer\'s protocol. Five and six silent mutations were placed, respectively, in the coding sequences of Bcl-x~L~ and Drp1, cloned in Flag and HA tag vectors. The sense sequences for the mutagenesis primers were: 5\'-cccagaaaggatacagctggagCcaAttCagCgaCgtggaagagaacaggactgagg-3\' for Bcl-x~L~ and 5\'-caacacggtgggcgccgacGtcGtcTagTtgTctTaaatcgtcgtagtgggaac-3\' for Drp1.

Design of Bcl-x~L~ mutants and Bcl-x~L~ -- Drp1 Interaction by co-immunoprecipitation {#S16}
-------------------------------------------------------------------------------------

In order to identify the specific Drp1-interacting domains on Bcl-x~L~, BLAST analysis was performed to identify the conserved amino acids between human Bcl-x~L~ and CED-9 protein sequences. Two mutant constructs were produced each carrying three substitutions for completely conserved amino acids on the BH1 or BH2 domains of Bcl-x~L~ using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies, USA) and the following primers: M1 5\'-gtcgcattgtggcctttttctactgctgcggggcactg-3\'; 5\'-cagtgccccgcagcagtagaaaaaggccacaatgcgac-3\' M2 5\'-ccaggagaacggcggctcggttacttgtgtggaactctatgg-3\'; 5\'-ccatagagttccacacaagtaaccgagccgccgttctcctgg-3\'. The resulting mutations were: (M1: S145Y, F146C, G147C) (M2: W188S, D189V, F191C) ([Fig. 7A](#F7){ref-type="fig"}). The constructs were expressed in 293T cells and immunoprecipitated, using the EZview\^™ Red ANTI-FLAG\^® M2 Affinity Gel (Sigma, USA), according to the manufacturer\'s protocol. The IP samples were examined by Western blot analysis using a rabbit anti-Bcl-x~L~ (Cell Signaling Technology) and a rabbit anti-Drp1 antibody (Santa Cruz Biotechnology)(for details see immunoblot section of methods).

Fluorescent measurement of pre-synaptic activity, using SynaptopHluorin {#S17}
-----------------------------------------------------------------------

Neurons were co-transfected with RFP-Bcl-x~L~ or mito-RFP and SynaptopHluorin constructs using 2.5M calcium phosphate on DIV-5. Transfection efficiency was about 1--5%. The SynaptopHluorin-expressing neurons were assayed on DIV 14-18. The coverslips were mounted in the field stimulation chamber (platinum bath electrodes) on the stage of a microscope. The 50μl chamber was perfused at a rate of 2 ml/min at room temperature with saline solution containing in mM: 119 NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2, 25 HEPES, 30 glucose (buffered to pH 7.4, 300 mOsm). 10uM CNQX, 50uM AP5 (Sigma, USA) were added into the solution to prevent recurrent activity. Neurons were stimulated at 10Hz (50 mA, 1 ms pulses) for 20s. After 5 min at rest neurons were stimulated again at 10Hz for 20s in the presence of 5μM bafilomycin A1 (Calbiochem/ EMD Biosciences, CA). Fluorescence values for baseline were obtained by averaging 3 images at rest before the stimulus. Time course of fluorescence responses of sPH were measured from time-lapse images taken every 3 seconds. Quantitative measurements of fluorescence intensity at individual boutons were obtained by averaging 4×4 area pixels (0.4 × 0.4 um^2^) corresponding to the center of individual puncta, selected by hand, background subtracted, and processed using Axiovision Measurement Suite.

Fluorescent measurement of pre-synaptic activity, using FM5-95 dye {#S18}
------------------------------------------------------------------

FM5-95 dye (Molecular Probes) was used at a final concentration of 30μM. 10μM CNQX and 50μM AP5 (Sigma, USA) were added into Tyrode\'s solution to prevent recurrent activity. Experiments were done in pairs of control and Bcl-x~L~ over-expressing neurons. All experiments were performed at room temperature.

### 1.Recycling pool loading protocol {#S19}

FM5-95 dye was added to 47mM high K Tyrode\'s solution (47mM KCl, 107mM NaCl, 2mM MgCl~2~, 10mM glucose, 10mM HEPES, 2mM CaCl2 (pH 7.4, 300 mOsm)) and put on cultured rat hippocampal cells. Neurons were given 90s to load the dye, after which it was washed out with perfusion (2.5ml/min) of a modified Tyrode\'s wash solution (no-Ca^2+^) containing 150mM NaCl, 4mM KCl, 2mM MgCl2, 10mM glucose, 10mM HEPES (pH 7.4, 300mOsm). Wash was performed for 2 min. 90 images were taken with a 1 second interval between each while cells were being stimulated with 90mM KCl in Tyrode\'s solution (90mM KCl, 64mM NaCl, 2mM MgCl~2~, 10mM glucose, 10mM HEPES, 2mM CaCl~2~ (pH 7.4, 300mOsm).

### 2. Extended Load time protocol {#S20}

FM5-95 dye was added to 47mM K+ Tyrode\'s solution for 90s. The High KCl-containing solution was washed out (2.5 ml/min) with modified Tyrode\'s wash solution containing FM 5-95 for 5min. Then, the dye was washed out by modified Tyrode\'s wash solution (2 min, 2.5 ml/min) lacking FM5-95 for 2 min. Cells were stimulated with 90mM high K^+^ Tyrode\'s solution for 90s, while images were taken with a 1 second interval between each image.

### 3. Delayed labeling protocol {#S21}

Cells were stimulated with 47mM KCl for 90s without FM5-95 dye, followed by a constant wash (2 min, 2.5ml/min) for 2-4 min. FM5-95 dye was then added to the wash for 90s followed by a wash (2 min, 2.5ml/min). Cells were then stimulated with 90mM high K Tyrode\'s solution while 90 images were taken with a 1 second interval between each image.

Image Analysis {#S22}
--------------

Images were analyzed using Axiovision LE software and Microsoft Excel. The fluorescence signal of each SV punctum (4× 4 area pixels) was outlined and measured for all 90 images. A background measurement for each image was subtracted from the measurement of each punctum.

Calcium measurement {#S23}
-------------------

Neurons were loaded with 5μM fluo-4AM calcium indicator (Molecular Probes: F14201) and incubated at 37°C for 30min in dark. Fluorescent axonal varicosities correspond to synaptic boutons along hippocampal cell axons detected in phase images of the cultured neurons according to the methods of ^[@R65]^.

Fluorescence values for baseline were obtained by averaging 3 images at rest before the stimulus. Cells were stimulated with 100 stimuli (50mA, 1ms) at10Hz. Time course of fluorescence responses of dye were measured from time-lapse images, taken every 3 seconds. 5 regions of interest (ROI\'s) were selected per image and the average background value was subtracted from the signal value from each pixel in the field. Axiovision-4 software was used to collect time-lapse measurements. Quantitative measurements of fluorescence intensity of individual puncta were obtained by averaging 4×4 pixels (0.4 × 0.4um2). Experiments were done in pairs of control and Bcl-xL overexpressing neurons at 14DIV.

Immunoprecipitation and Western Blot analysis {#S24}
---------------------------------------------

Lysates of hippocampal cultures (DIV12) or adult whole brain were prepared with cell lysis buffer (10mM Hepes, 1mM EDTA (pH 7.4), 150mM NaCl, 1% Triton X-100, supplemented with protease inhibitors (Roche Applied Science)) for immunoprecipitation (IP) and Western blotting. Input represents 5% of total lysate. For translocation of endogenous Bcl-x~L~, all cultures over-express GFP-Bcl-x~L~ but the bands shown are those of endogenous Bcl-x~L~. All lanes contain 10 μg protein. For IP, cell lysate was mixed with primary antibody (1:1,000 dilution) in IP buffer (10mM Hepes, 1mM EDTA (pH 7.4), 150mM NaCl, 1% Triton X-100, supplemented with protease inhibitors) and incubated overnight at 4°C with gentle rocking. Protein A and G-Sepharose beads were added and allowed to incubate for 1 h. The unbound protein was removed by washing the beads three times in IP buffer. The bound protein was then eluted from the beads with SDS/PAGE sample buffer. Immunoprecipitated samples were analyzed by Western blotting, using previously published protocols (Li et al. 2008).

Western blot quantification {#S25}
---------------------------

The quantification of protein levels was done using (<http://rsb.info.nih.gov/ij/>). Each band was normalized against its own internal control (lower bands). The values from independent experiments were then normalized against the mean of the group.

Antibodies used for immunoblotting analysis {#S26}
-------------------------------------------

Rabbit anti-human Bcl-x~L~ (1:1000; A. G. Scientific) or rabbit mAb anti-Bcl-x~L~ antibody 54H6 (1:1000; Cell Signaling Technology) or Anti-Bcl-x~L~ &s (BIOCARTA**),** Rabbit polyclonal anti-Drp1 (H-300; sc-32898, 1:1000; Santa Cruz Biotechnology), Mouse Anti-Synaptotagmin1/2 Monoclonal Antibody, Unconjugated, Clone 1D12 **(**MBL International). Dynamin I/II Antibody (\#2342 1:1000 Cell Signaling Technology), GAPDH (6C5)(sc-32233 1:1000 ; Santa Cruz Biotechnology), COX-IV antibody \[20E8\] -Mitochondrial Loading Control (ab14744, 1:1000 abcam), Clathrin LCA (H-55): sc-28276, 1:1000; Santa Cruz Biotechnology), rabbit polyclonal antibody P/Q-type Ca++ CP α1A (H-90): sc-28619 from SANTA CRUZ BIOTECHNOLOGY, INC.(1:800), rabbit polyclonal antibody PSD95 from cell signaling (1:1000), Bassoon (D63B6) Rabbit mAb from cell signaling (1:1000); rabbit polyclonal anti-VDAC antibody (Cell signaling \#4866, 1:1000); mouse monoclonal anti-synaptophysin antibody (Millipore MAB368, 1:20 for EM); polyclonal rabbit anti-Mff antibody (Sigma HPA010968; 1:200); polyclonal rabbit anti-VAMP2 antibody (Synaptic Systems Cat No. 104 202; 1:20 for EM).

Sample Fixation for ImmunoElectron microscopy {#S27}
---------------------------------------------

Samples were fixed in 4% paraformaldehyde in 0.25M Hepes for 1 hour. Samples were rinsed in PBS and re-suspended in 10% gelatin, chilled and trimmed to smaller blocks and placed in cryoprotectant of 2.3M sucrose overnight on a rotor at 4C. They were transferred to aluminum pins and frozen rapidly in liquid nitrogen. The frozen block was trimmed on a Leica Cryo-EMUC6 UltraCut and 65-75nm thick sections were collected using the Tokoyasu method ^[@R66]^. The frozen sections were collected on a drop of sucrose, thawed and placed on a nickel formvar /carbon coated grid and floated in a dish of PBS ready for immunolabeling.

Immunolabeling of sections {#S28}
--------------------------

Grids were placed section side down on drops of 0.1M ammonium chloride to quench untreated aldehyde groups, then blocked for nonspecific binding on 1% fish skin gelatin in PBS. Single labeled grids were incubated on either a primary antibody rabbit anti-Bcl-X (Biocarta) 1:50, mouse anti-Clathrin (Chemicon) 1:75 dilutions for 30mins, or DRP1 (H-300): sc-32898 (1:50) from Santa Cruz Biotechnology, Inc. A rabbit anti mouse bridging antibody (Jackson) was used for the mouse primaries before rinsing and using 10nm protein A gold (UtrectUMC) for 30minutes. Double labeled grids used the primary rabbit anti-Bcl-X and 10nm protein A gold followed by rabbit anti-mouse bridge and the 5nm protein A gold. All grids were rinsed in PBS, fixed using 1% gluteraldehyde for 5mins, rinsed and transferred to a UA/methylcellulose drop, then dried for viewing. Samples were viewed FEI Tencai Biotwin TEM at 80Kv. Images were taken using Morada CCD and iTEM (Olympus) software.

Sample fixation for regular epon embedding (for studies with Drp1 shRNA) {#S29}
------------------------------------------------------------------------

Cells on coverslips were fixed in 2.5% gluteraldehyde in 0.1M sodium cacodylate buffer pH7.4 with for 1 hour. The samples were rinsed in sodium cacodylate postfixed in 1% osmium tetroxide for 1 hour, en bloc stained in 2% uranyl acetate in maleate buffer pH5.2 for a further hour then rinsed, dehydrated in an ethanol series and infiltrated with resin (Embed812 EMS). Resin filled gelatin capsules were inverted over the coverslip and baked overnight at 60°C. 60nm sections were cut using a Leica UltraCut UCT, collected on nickel formvar/carbon coated grids, stained using 2% uranyl acetate and lead citrate.

Protocol for HRP-staining neurons-Labeling endocytic vesicles with HRP {#S30}
----------------------------------------------------------------------

Neurons were rinsed with Tyrodes buffer and incubated with 10mg/ml HRP at 37°C for 20min. Cells were then stimulated with 90mM KCL for 90s following by 2X rinsing with ice cold Tyrodes buffer. Neurons were fixed for 1h with 1.2% glutaraldehyde and 0.1M NaCacodylate and incubated for 10min in 0.1M ammonium phosphate pH7.4. Neurons were incubated for another 10min in ammonium phosphate pH7.4. plus 0.5mg/ml diaminobenzidine(DAB) followed by incubation in 0.1M ammonium phosphate pH7.4, 0.5mg/ml DAB and 0.005% H~2~O~2~ for 5-15min (until brown color developed). Cells were rinsed 3X with cold water and fixed for 1h in 1%OsO~4~, 1%K~4~Fe(CN)~6~ and 0.1M Na Cacodylate, following with 3X5min washes with 0.1M NaCacodylate and 3x5min washes with water. Cells were stained overnight with 0.5% Uranyl magnesium acetate (2μm filtered) and washed 3x5min with water, 2x5min with 70% EtoH, 2x15min with 95% EtoH, 2x30min with 100% EtoH, 1 hr with 1:1 Epon-EtOH and 2x1hr with Epon. Cells were then embedded and baked for 48hr at 65°C.

Subcellular fractionation {#S31}
-------------------------

Mitochondrial, synaptosomal and cytosolic fractions were prepared according to the manufacturers protocol (Millipore Cat. No. MIT1000). Briefly, cultured neurons were homogenized in isotonic Mitochondrial Buffer and centrifuged at 600xg for 10min at 4°C. The pellet, containing the nuclear and unbroken cells was discarded and the supernatant, containing the mitochondrial, synaptosomal and cytosolic fractions was centrifuged at 10,000xg for 30min at 4°C. The supernatant, containing the cytosolic fraction was separated from the pellet. The pellet containing the mitochondrial and synaptosomal fractions was resuspended in 100μL isolation buffer and layered onto a 7.5-10% Ficoll gradient. After 30min ultracentrifugation at 90,000xg, 4°C, the mitochondrial pellet and the middle layer, containing synaptosomes were removed and resuspended in isolation buffer and centrifuged for 10 min at 20,000xg, resulting in a crude synaptosomal pellet. Synaptosomal pellet was lysed by hypoosmotic shock in water. The samples were agitated for 30min in 4mM Hepes at 4°C, synaptosomal pellet was centrifuged for 20min at 25,000×g, resulting in a synaptosomal membrane fraction (pellet) and a synaptic vesicle fraction. The latter was used for immunoblots.

Electrophysiology {#S32}
-----------------

Whole-cell patch-clamp recordings were performed on autaptic hippocampal neurons in culture. Data were acquired using a EPC8 amplifier and Clampex 9.0 software. Recordings were filtered at 1 kHz and sampled at 2 ms. The bath solution contained the following (in mM): 124 NaCl, 3 KCl, 10 HEPES, 5 D-glucose, 2 CaCl2, 1 MgCl2, pH7.3, 275 mOsm. The pipette internal solution contained the following (in mM): 120 K-gluconate, 8 NaCl, 0.5 EGTA, 10 HEPES, 1 Mg-ATP, 10 QX-314. pH7.3. 265 mOsm. Stimulation was applied by depolarizing the cell via the recording electrode with the following membrane potential steps: −60mV, 20mV and −60mV, at 10 Hz. Synaptic current responses to depolarization were recorded at −60mV. Such currents were eliminated in the presence of CNQX/APV (data not shown). Series resistance ranged between 6-20 MΩ.

Luciferase assay for *in vitro* ATP measurements {#S33}
------------------------------------------------

Cellular ATP levels were measured upon acute cell membrane lysis of hippocampal neurons in a plate reader (Perkin-Elmer) in the presence of Luciferin/luciferase (ApoSENSOR, Biovision, Mountain View, CA).

Antibodies used in studies {#S34}
--------------------------

Rabbit mAb anti-Bcl-xL antibody 54H6 (\#2764, Cell Signaling Technology, 1:1000;), Rabbit Anti- Bcl-xL &s (\#IMG 276, BIOCARTA), Rabbit anti-human Bcl-xL (\#B1225, A. G. Scientific,1:1000;), Rabbit anti-Drp1 (sc-32898, Santa Cruz 1:1000), Mouse Anti-Synaptotagmin1/2 Monoclonal Antibody, Unconjugated, Clone 1D12 (\#D156-3, MBL International, 1:1000), Dynamin I/II Antibody (\#2342 ,1:1000 Cell Signaling Technology), mouse anti-GAPDH (6C5) (sc-32233 ,1:1000 ; Santa Cruz Biotechnology), COX-IV antibody \[20E8\] -Mitochondrial Loading Control (ab14744, 1:1000 , abcam), Clathrin LCA (H-55): (sc-28276, 1:1000; Santa Cruz Biotechnology), Rabbit polyclonal antibody P/Q-type Ca++ CP 1A (H-90): sc-28619 Santa Cruz Biotechnology 1:800, Rabbit polyclonal antibody PSD95 (\#2507, cell signaling ,1:1000), Rabbit mAb Bassoon (D63B6) ( \#6897, cell signaling ,1:1000), Rabbit anti-VDAC (\#4866, Cell Signaling, 1:1000), mouse monoclonal anti-synaptophysin antibody (clone SVP-38, \#MAB368, 1:20 for EM, Millipore), polyclonal rabbit anti-Mff antibody (HPA010968; Sigma ,1:200), polyclonal rabbit anti-VAMP2 antibody (\#104202; 1:20 for EM Synaptic Systems).

Statistical Methods {#S35}
-------------------

Statistical analysis. For comparisons involving two groups, paired or unpaired Student\'s t -tests (two-tailed) were used. In all figures, \*=P \< 0:05, \*\*= P \< 0:01 and \*\*\*=P \<0:001 denote significance level, and exact P values are provided in the figure legends.

Supplementary Material {#SM}
======================

The authors wish to acknowledge Len Kaczmarek for thoughtful discussions of the data. The authors also thank Dr. Gero Meisenbock for providing Synapto-pHluorin for the sPH studies.

![Bcl-x~L~ over-expression enhances the rate of release of styryl dyes in hippocampal neurons\
a. Diagram of protocols for experiments (1-3) described in text.\
b. Examples of exponential fits to normalized fluorescence change of FM 5-95 puncta during stimulation with 90 mM KCl. Left panel: Bi-exponential fit to normalized fluorescence change from cells over-expressing Bcl-x~L~ (ExpDec2 of Bcl-x~L~=bi-exponential decay of fluorescence). Center panel: Dotted lines model two different exponents of left panel (ExpDec of Bcl-x~L~=bi-exponential fit to fluorescence decay shown as one dotted line for each exponent). Right panel: Single exponential fit to the normalized fluorescence change from a GFP control neuron (ExpDec1 of control=single exponential decay of fluorescence).\
c. Time course of normalized fluorescence of 5 μM Fluo-4 measured in synaptic boutons during electrical stimulation (100 action potentials at 10 Hz; n=15 DsRed expressing cells, n=15 DsRed-Bcl-x~L~ expressing cells).\
d. Peak fluorescence after loading with Exp 1 protocol (prior to unloading) of individual FM 5-95 puncta (n=10 GFP CTL puncta, 14 GFP- Bcl-x~L~ puncta; \*\*p \< 0.0013; three independent cultures). In all experiments, Bcl-x~L~ expressing and GFP-expressing controls are pairs from the same culture.\
e. Normalized fluorescence change in 90 mM KCl (n=10 GFP CTL puncta, 14 GFP- Bcl-x~L~ puncta).\
f. Time constants for exponential fits to all experiments in e.\
g. Relative weights of exponential pools for experiments in e.\
h. Peak fluorescence of FM 5-95 puncta (protocol for Exp 2); n=14 GFP CTL puncta, 15 GFP-Bcl-x~L~ puncta; three independent cultures; \*\*\*p \< 0.0001).\
i. Normalized fluorescence change in 90 mM KCl (Exp 2 protocol; n=14 GFP CTL puncta, 15 GFP-Bcl-x~L~ puncta).\
j. Time constants for exponential fits to experiments in i.\
k. Relative weights of exponential pools for experiments in i.\
l. Peak fluorescence of FM 5-95 puncta (Exp 3 protocol; n=11 GFP CTL puncta, 20 GFP-Bcl-x~L~ puncta; three independent cultures).\
m. Normalized fluorescence change in 90 mM KCl (Exp 3 protocol; n=5 GFP CTL puncta, 10 GFP-Bcl-x~L~ puncta). The initial 10 s of fluorescence decline is shown. 5 CTL puncta are represented to emphasize the bi-exponential effect found in a subgroup of CTL puncta. No punctal fluorescence changes from GFP-Bcl-x~L~ expressing cells required bi-exponential fits.\
n. Time constants for exponential fits to experiments such as in m (n=9 GFP CTL puncta, n=10 GFP-Bcl-x~L~ puncta).\
o. Relative weights of exponential pools for experiments in m. Statistics are represented as mean +/- S.E.M.](nihms-495805-f0001){#F1}

![Endogenous Bcl-x~L~ participates in normal vesicle pool dynamics\
a. Diagram of protocol 1 for all experiments in Figure 2.\
b. Peak fluorescence of FM 5-95 puncta (n=13 scrambled shRNA, 10 Bcl-x~L~ shRNA; \*p\<0.03; puncta from 5 different cells, three independent cultures).\
c. Normalized fluorescence in 90 mM KCl (n=9 scrambled shRNA, n=7 Bcl-x~L~ shRNA; 5 different cells, three independent cultures.\
d. Time constants for exponential fits to experiments in c (n=12 scrambled shRNA, n=7 Bcl-x~L~ shRNA \*\*\*p\< 0.0001 comparing tau 2 for the two conditions).\
e. Relative weights of two exponential pools for experiments in c.\
f. Peak fluorescence of FM 5-95 in CTL and CaMi-treated cells (n=10 puncta each; \*\*p\<0.003; 5 different cells each from three independent cultures). Cells were exposed to 30 μM CaMi or vehicle for 30 min. prior to loading with FM 5-95.\
g. Normalized fluorescence in 90 mM KCl (n=10 CTL, n=8 puncta of CaMi-treated cells; 5 different cells for each condition from three independent cultures).\
h. Time constants for exponential fits to experiments in g (\*\*\*p=0.0009).\
i. Relative weights of exponential pools for experiments in g.\
j. Peak fluorescence of FM 5-95 puncta in GFP-Bcl-x~L~ expressing cells and GFP-Bcl-x~L~ expressing cells treated with CaMi (n=8 each; 3 different coverslips in each condition).\
k. Normalized fluorescence in 90 mM KCl (n=7 GFP- Bcl-x~L~ and 8 GFP- Bcl-x~L~ + CaMi puncta; 3 different cells for each condition).\
l. Time constants for exponential fits to experiments in k (n=12 GFP- Bcl-x~L~ and 7 GFP- Bcl-x~L~ + CaMi puncta; \*\*p=0.0069, comparing tau 1 for the two conditions).\
m. Relative weights of exponential pools for experiments in k. Statistics are represented as mean +/- S.E.M.](nihms-495805-f0002){#F2}

![Bcl-x~L~ increases the rate of mitochondrial ATP-resistant early endocytosis\
a. Normalized fluorescence change of synaptopHluorin puncta before, during and after electrical stimulation (with 100 action potentials, 10 Hz; n=15 puncta from DsRed-Bcl-x~L~ cells, n=15 mito-RFP CTL). Inset: time constants of change in fluorescence after stimulation (\*\*\*p=0.0002; 3 independent cultures. Experiment repeated with 8 different cultures.\
b. Normalized fluorescence (n=15 DsRed control puncta before and after 5 μM bafilomycin). Non-normalized data: [Suppl. Fig. 5a](#SD6){ref-type="supplementary-material"}.\
c. Normalized fluorescence (n=15 DsRed Bcl-x~L~ puncta before and after bafilomycin).\
d. Ratio of difference in peak fluorescence before and after bafilomycin to peak in bafilomycin of traces in b and c (\*\*\*p\< 0.0001).\
e. Normalized fluorescence (n=15 puncta from each DsRed-Bcl-x~L~ shRNA or DsRed (CTL) cells). Inset: time course of change in fluorescence after stimulation (n=15 puncta each group; \*p=0.0203; 3 independent cultures).\
f. Normalized fluorescence (n=15 puncta from DsRed controls before and after bafilomycin).\
g. Normalized fluorescence (n=15 puncta from DsRed Bcl-x~L~ shRNA before and after bafilomycin).\
h. Ratio of difference in peak fluorescence before and after bafilomycin over peak in bafilomycin of traces in f and g (\*\*\*p\< 0.0001).\
i. Normalized fluorescence (n=15 puncta from DsRed control or DsRed Bcl-x~L~ shRNA, or both DsRed Bcl-x~L~ shRNA plus shRNA-resistant Bcl-x~L~; 3 independent coverslips in each group.\
j. Normalized fluorescence for vehicle or 5 min. after exposure to 10 μM ABT-737; N=6). Inset: time constants of fluorescence changes (\*p\<0.02).\
k. Phase image of single autaptic hippocampal neuron in culture DIV 16. Scale bar= 20 μm.\
l. Synaptic depression of GFP-Bcl-x~L~ or control GFP (10 Hz stimulation, first and last 10 of 100 synaptic responses).\
m. Summary data of percentage change in average amplitude of last 10 compared to first 10 synaptic responses (n=8 control GFP and 9 GFP-Bcl-x~L~ cells, two independent cultures; \*p = 0.017).\
n. ATP levels (luciferin/luciferase) of lysed neurons expressing the indicated constructs; oligomycin=5 μg/ml for 5 min; n=12 wells each group,\*\*\* p\<0.0001).\
o. Normalized fluorescence in 5 μg/ml oligomycin (stimulation 5 min. after oligomycin application n=10 puncta each from DsRed-Bcl-x~L~ or mito-RFP (CTL) expressing cells).\
p. Time constants of change in fluorescence after stimulation for data in o (n=10 each for oligomycin; \*\*\*p\<0.0001 comparing Bcl-x~L~ to control; non-oligomycin puncta n=37 for each condition, \*\*\*p\<0.0001 comparing Bcl-x~L~ to control; oligomycin CTL data compared to non-oligo control data; \*\*\*p\<0.0001; Bcl-x~L~ oligomycin-treated compared to non-oligomycin \*\*\*p=0.0005).\
q. Normalized fluorescence before and after 5 μM bafilomycin in oligomycin-treated cells (n=10 puncta, three independent cover slips; mito-RFP controls).\
r. Normalized fluorescence before and after 5 μM bafilomycin (n=10 puncta, three independent cover slips, DsRed-Bcl-x~L~).\
s. Ratio of difference in peak fluorescence before and after bafilomycin over peak in bafilomycin of traces shown in q and r (\*\*\*p\< 0.0001). Statistics are represented as mean +/- S.E.M.](nihms-495805-f0003){#F3}

![Calmodulin-dependent Bcl-x~L~ translocation to synaptic vesicle membranes in stimulated neurons\
a. Immunoblots for Bcl-x~L~ of indicated sub-fractions of cell lysates of cultured unstimulated hippocampal neurons or stimulated with 90 mM KCl for 90 s with or without CaMi. GAPDH serves as protein control for cytosolic protein amount, COX IV as control for mitochondrial protein amount, synaptotagmin as control for synaptic vesicle membrane protein amount.\
b. Group data for protein densities for all experiments in a (n=3 blots; \*p \< 0.03, one-tailed unpaired student\'s t test of protein amount after stimulation compared to before stimulation; \*\*p \< 0.009, one-tailed unpaired student\'s t test of protein amount after stimulation compared to before stimulation).\
c. Immunoblots for Bcl-x~L~ of indicated sub-fractions of cell lysates of cultured unstimulated or stimulated neurons. The right lane of each cell subfraction indicates level of Bcl-x~L~ from cells transduced with DsRed calmodulin shRNA. GAPDH serves as protein control for cytosolic protein amount, COX IV as control for mitochondrial protein amount, synaptotagmin as control for synaptic vesicle membrane protein amount.\
d. Group data for protein densities for all experiments in c (n=3 blots; \*p \< 0.03, \*\*p=0.0081 one-tailed unpaired student\'s t test of protein amount after stimulation compared to before stimulation).\
e. Normalized (to starting value) fluorescence change of synaptopHluorin puncta before, during and after electrical stimulation (with 100 action potentials, 10 Hz; n=10 puncta from DsRed expressing cells before and after 5 μM bafilomycin).\
f. Normalized fluorescence change (n=10 puncta from DsRed CaM shRNA expressing cells before and after bafilomycin.\
g. Ratio of difference in peak fluorescence change before and after bafilomycin to the peak fluorescence in bafilomycin of traces shown in e and f (\*\*p=0.006).\
h. Normalized fluorescence change (n=10 puncta for calmodulin shRNA or scrambled shRNA; 3 cells each, one culture). Inset: bar graphs of time constants of fluorescence changes (\*p=0.038). Statistics are represented as mean +/- S.E.M.](nihms-495805-f0004){#F4}

![Drp1 is co-localized with clathrin and Mff on synaptic vesicles\
a. Immuno-electron micrographs of Drp1 on clathrin-coated pits. Cultured hippocampal neurons were stimulated with 90 mM KCl for 90 s prior to fixation for electron microscopy (EM).\
b. Co-immunoprecipitation of whole rat brain lysate using indicated antibodies (IP refers to antibodies used for immunoprecipitation. Titles at right of blot refer to antibodies used for immunoblotting. Left lane represents cell lysate).\
c. Immunoblots of subcellular fractions (as indicated) of rat brain lysate using the indicated antibodies. Left lane shows cell lysate.\
d. Co-immunoprecipitation of purified synaptic vesicle fraction using the indicated antibodies (left lane represents cell lysate).\
e. Normalized fluorescence change before, during and after electrical stimulation (n=15 puncta from DsRed controls or DsRed Drp1 shRNA; 3 independent cultures each group.\
f. Normalized fluorescence change (n=15 puncta each DsRed control (red trace, same control data as for Bcl-x~L~ shRNA in 3i), DsRed Drp1 shRNA expressing cells (black trace), or from cells expressing both DsRed Drp1shRNA plus Drp1 shRNA-resistant Drp1 overexpressing construct (blue trace). 3 independent cultures).\
g. Normalized fluorescence change (n=15 puncta from DsRed control expressing cells before and after bafilomycin). These control data are the same as the DsRed control data in [Fig. 3f](#F3){ref-type="fig"} but are provided here for comparison to 5h.\
h. Normalized fluorescence change (n=15 puncta from DsRed Drp1 shRNA expressing cells before and after bafilomycin).\
i. Peak fluorescence change ratios of traces shown in g and h (\*\*\*p\< 0.0001).\
j. Co-immunoprecipitation of whole rat brain lysate using indicated antibodies (IP refers to antibodies used for immunoprecipitation; Titles at right of blot refers to antibodies used for immunoblotting. Left lane represents cell lysate).\
k. Normalized fluorescence change; n=12 puncta from scrambled shRNA expressing cells before and after 5 μM bafilomycin, 12 different coverslips, 2 independent cultures.\
l. Normalized fluorescence change; n=12 puncta from Mff shRNA expressing cells before and after bafilomycin, 13 different coverslips, 2 independent cultures.\
m. Peak fluorescence change ratios of traces shown in k and l (\*\*\*p\< 0.0001). Statistics are represented as mean +/- S.E.M.](nihms-495805-f0005){#F5}

![Bcl-x~L~ and Drp1 co-localize with synaptophysin on synaptic vesicles\
a. Immuno-electron micrographs co-localizing clathrin and Bcl-x~L~. Cultured hippocampal neurons were stimulated with 90 mM KCl for 90 s just prior to fixation for EM.\
b. Co-immunoprecipitation using indicated antibodies (IP refers to antibody used for immunoprecipitation; antibodies used for immunoblotting are labeled at right). Left lane represents cell lysate.\
c. Average number of gold particles in electron micrographs of synapses. n=25 micrographs of non-stimulated cells, n=27 micrographs of stimulated cells. First two histograms represent clathrin-labeled particles, second two histograms represent Bcl-x~L~-labeled particles, third set of histograms represents co-localizing Bcl-x~L~- and clathrin-labeled particles on the same synaptic vesicle (p=0.0014).\
d. (Top) Immuno-electron micrographs showing co-localization of Drp1 and synaptophysin in unstimulated (left panel) and stimulated synapses (right panel). (Bottom) Immuno-electron micrographs showing co-localization of Bcl-x~L~ and synaptophysin in unstimulated (left panel) and stimulated synapses (right panel).\
e. Average number of gold particles in electron micrographs of synapses treated with antibodies and stimulation as labeled (left to right: n=20, 17, 20, 17, 11, 11, 11, 11; \*\*p=0.0081 (Drp1 nonstim. vs. Drp1 stim.). \*\*\*p\<0.0001 (co-localization of Drp1 and synaptophysin non-stim. vs. stim.). \*p=0.0356 (Bcl-x~L~ non-stim. vs. Bcl-x~L~ stim.). \*\*p=0.0019 (co-localization of Bcl-x~L~ and synaptophysin non-stim. vs. stim.).\
f. (Left top) Immuno-electron micrographs showing co-localization of Bcl-x~L~ (10 nm gold balls) and synaptophysin (5 nm gold balls). (Left bottom) Immuno-electron micrographs showing co-localization of Drp1 (10 nm gold balls) and synaptophysin (5 nm gold balls). In the schematic diagrams to the right of, and superimposed on, the images, the presynaptic membrane is colored in light blue, synaptic vesicles are colored in red, gold balls indicating Bcl-x~L~ or Drp1 antibody labeling are colored in dark blue, gold balls indicating synaptophysin antibody labeling are colored in yellow, green indicates mitochondria. Enlarged insets show synaptophysin, Drp1 and Bcl-x~L~ immunolabeling (yellow arrows indicate synaptophysin antibody labeling, blue arrows indicate Bcl-x~L~ (top two images) or Drp1 (bottom two images). The right-most panels picture mitochondria (top shows Bcl-x~L~ immunolabeling, bottom shows Drp1 immunolabeling. Statistics are represented as mean +/- S.E.M.](nihms-495805-f0006){#F6}

![Drp1 is required for formation of normal endocytotic vesicles\
a. Electron micrographs of resting synapses of hippocampal neurons transduced with scrambled GFP-shRNA. Red arrows demonstrate representative control synaptic vesicles. Scale bar is shown in 7b.\
b. Electron micrographs of resting synapses of hippocampal neurons transduced with GFP-Drp1 shRNA. Black arrows indicate enlarged vesicles and (in lower right hand panel) a vesicle with an elongated neck. White arrows indicate clathrin-coated pits, which tend to be more frequently seen in micrographs of synapses of Drp1 shRNA expressing neurons. Scale bar = 500 nm.\
c. Histograms of all vesicle area measurements (n=6 micrographs of scrambled shRNA expressing neurons, 347 vesicles; n=8 micrographs of Drp1 shRNA expressing neurons, 667 vesicles.\
d. Electron micrographs of stimulated synapses of hippocampal neurons transduced with scrambled GFP shRNA (top image) or with GFP Drp1 shRNA (bottom image); blots were fixed just after stimulation with 90 mM KCl in the presence of horse radish peroxidase (HRP). Scale bar = 200 nm. Red arrows demonstrate HRP-labeled vesicles in controls, black arrows demonstrate HRP-labeled vesicles in Drp1 shRNA. White arrow shows an endocytotic pit pinching off the plasma membrane.\
e. Quantification of area (μm^2^) of all HRP-labeled vesicles (n=9 images, 98 total vesicles for control; n=11 images, 127 total vesicles for Drp1 shRNA, \*\*\*p\<0.0001).\
f. Cryo-electron micrographs immuno-labeled with gold-tagged anti-VAMP antibodies after stimulation. Scale bar = 200 nm.\
g. Electron micrographs of synapses of hippocampal neurons transduced with scrambled GFP shRNA (top images) or with GFP Drp1 shRNA (bottom images). Left panels represent unstimulated synapses, right panels represent stimulated synapses. Scale bar = 500 nm.\
h-i. Histograms of all vesicle area measurements (μm^2^) from panels in f, g (n=8 micrographs of control scrambled shRNA unstimulated synapses, n=5 micrographs of control scrambled shRNA stimulated synapses, n=9 micrographs of Drp1 shRNA unstimulated synapses, n=12 micrographs of Drp1 shRNA stimulated synapses, n=19 micrographs of Drp1 shRNA synapses immunogold labeled with anti-VAMP antibodies).\
j. Quantification of number of vesicles in synapses such as shown in g (n=9 micrographs (synapses) each for unstimulated and stimulated scrambled shRNA, 9 micrographs for unstimulated Drp1 shRNA, 11 micrographs for stimulated Drp1 shRNA; \*p = 0.0306, \*\*p = 0.002, \*\*\*p\<0.0001).\
k. Quantification of synapse area (μm^2^) of all synapses measured in j (\*p=0.043; \*\*p=0.007, \*\*\*p\<0.0001). Statistics are represented as mean +/- S.E.M.](nihms-495805-f0007){#F7}

![Mutations in BH2 domain of Bcl-x~L~ disrupt physical and functional interaction with Drp1\
a. CED-9 and Bcl-x~L~ protein sequences. Green and yellow boxes specify BH1 and BH2 domains, respectively. Red boxes denote conserved mutated amino acids within each domain.\
b. Immunoprecipitation by an anti-FLAG antibody of the wild type and mutant (M1 and M2) FLAG-tagged Bcl-x~L~ proteins. Samples were immunoblotted for Drp1 and Bcl-x~L~. Lysate studies are shown in the right panel.\
c. Normalized (to starting value) fluorescence change of synaptopHluorin puncta in hippocampal neurons expressing indicated constructs before, during and after electrical stimulation (with 100 action potentials, 10 Hz), n=10 puncta each from 3 cells each from one culture.\
d. Group data for all experiments shown in c (\*p=0.0169; \*\*\*p=0.0004).\
e. Model showing order of events: 1) Neuronal stimulation leads to calcium influx. 2) Calcium binds to and activates Calmodulin (CaM), which is inhibited by calmidazolium (CaMi). 3) CaM causes the translocation of Bcl-x~L~ and Drp1 to clathrin-coated pits where Bcl-x~L~ binds to and activates Drp1. 4) Drp1 is in part responsible for the formation of normally curved endocytotic vesicles. Knock down or functional inhibition of Bcl-x~L~, Drp1 or CaM disrupts this process, slowing endocytosis.](nihms-495805-f0008){#F8}
